Mortality after hydroxyethyl starch 130/0.4 infusion: an updated meta-analysis of randomized trials
BACKGROUND: Hydroxyethyl starch (HES) is in widespread clinical use for volume therapy with colloids. According to the most recent meta-analysis performed in 2010, published studies are of poor quality and report too few events to reliably estimate the benefits or risks of administering 6% HES...
-д хадгалсан:
| Үндсэн зохиолчид: | , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2012-07-01
|
| Цуврал: | Swiss Medical Weekly |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://www.smw.ch/index.php/smw/article/view/1555 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|